BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23943231)

  • 1. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.
    Thompson CM; Kirman CR; Proctor DM; Haws LC; Suh M; Hays SM; Hixon JG; Harris MA
    J Appl Toxicol; 2014 May; 34(5):525-36. PubMed ID: 23943231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium.
    Thompson CM; Kirman CR; Hays SM; Suh M; Harvey SE; Proctor DM; Rager JE; Haws LC; Harris MA
    J Appl Toxicol; 2018 Mar; 38(3):351-365. PubMed ID: 29064106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and carcinogenesis studies of sodium dichromate dihydrate (Cas No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Jul; (546):1-192. PubMed ID: 18716633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice.
    Bucher JR
    Toxic Rep Ser; 2007 Jan; (72):1-G4. PubMed ID: 17342194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.
    Thompson CM; Seiter J; Chappell MA; Tappero RV; Proctor DM; Suh M; Wolf JC; Haws LC; Vitale R; Mittal L; Kirman CR; Hays SM; Harris MA
    Toxicol Sci; 2015 Jan; 143(1):16-25. PubMed ID: 25352572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.
    Thompson CM; Proctor DM; Suh M; Haws LC; Kirman CR; Harris MA
    Crit Rev Toxicol; 2013 Mar; 43(3):244-74. PubMed ID: 23445218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium.
    Kirman CR; Hays SM; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM
    Chem Biol Interact; 2012 Oct; 200(1):45-64. PubMed ID: 22981460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy.
    Thompson CM; Wolf JC; Elbekai RH; Paranjpe MG; Seiter JM; Chappell MA; Tappero RV; Suh M; Proctor DM; Bichteler A; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():61-6. PubMed ID: 26232259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium.
    Thompson CM; Proctor DM; Haws LC; Hébert CD; Grimes SD; Shertzer HG; Kopec AK; Hixon JG; Zacharewski TR; Harris MA
    Toxicol Sci; 2011 Sep; 123(1):58-70. PubMed ID: 21712504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
    Bhat VS; Cohen SM; Gordon EB; Wood CE; Cullen JM; Harris MA; Proctor DM; Thompson CM
    Crit Rev Toxicol; 2020 Sep; 50(8):685-706. PubMed ID: 33146058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of non-linear, non-threshold and threshold approaches for assessing the carcinogenicity of oral exposure to hexavalent chromium.
    Haney J
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):834-52. PubMed ID: 26493004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water.
    Kopec AK; Kim S; Forgacs AL; Zacharewski TR; Proctor DM; Harris MA; Haws LC; Thompson CM
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):13-26. PubMed ID: 22155349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
    Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
    J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity and genome-wide microarray analysis of intestinal smooth muscle cells in response to hexavalent chromium induction.
    Jin LF; Wang YY; Zhang ZD; Yuan YM; Hu YR; Wei YF; Ni J
    Dongwuxue Yanjiu; 2013 Jun; 34(E3):E93-100. PubMed ID: 23776007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferred inactivation of the Cftr gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.
    Mezencev R; Auerbach SS
    Toxicol Appl Pharmacol; 2021 Dec; 433():115773. PubMed ID: 34688701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexavalent chromium (Contaminants).
    Food Safety Commission of Japan
    Food Saf (Tokyo); 2019 Jun; 7(2):56-57. PubMed ID: 31998588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action.
    Thompson CM; Proctor DM; Suh M; Haws LC; Hébert CD; Mann JF; Shertzer HG; Hixon JG; Harris MA
    Toxicol Sci; 2012 Jan; 125(1):79-90. PubMed ID: 22011396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure.
    Stout MD; Herbert RA; Kissling GE; Collins BJ; Travlos GS; Witt KL; Melnick RL; Abdo KM; Malarkey DE; Hooth MJ
    Environ Health Perspect; 2009 May; 117(5):716-22. PubMed ID: 19479012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a chronic noncancer oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling.
    Thompson CM; Gaylor DW; Tachovsky JA; Perry C; Carakostas MC; Haws LC
    J Appl Toxicol; 2013 Dec; 33(12):1395-406. PubMed ID: 22936336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human health risk and exposure assessment of chromium (VI) in tap water.
    Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
    J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.